Our Financial Results

Foundation Biomedical Primate Research Centre (BPRC) closed the fiscal year 2022 with a negative result of 8 K€.

Total turnover projects decreased from 13,9 million euros in 2021 to 13,2 million euros in 2022, a difference of 0,7 million euros. The decrease in income commissioned by third parties is caused by the TB Vaccin project which did not start in 2022 but will start in 2023.

The operational costs are three percent lower than the budget for the year 2022.


Financial statements (PDF) Executives' Pay (Standards) Act (PDF)